Search for: "Wyeth Pharmaceuticals"
Results 381 - 400
of 976
Sort by Relevance
|
Sort by Date
23 Feb 2011, 7:37 am
Tags: labor unions, Milwaukee, pharmaceuticals, sex discrimination, Wisconsin Related posts Milwaukee law firms in Google keywords dustup (0) Your Prisoner Sex Change Update (17) Wyeth v. [read post]
23 Feb 2011, 6:27 am
In 2010, with $10.8 billion in sales, Lipitor still accounted for 15.8% of total revenue, even with the addition of Wyeth's operations. [read post]
23 Feb 2011, 5:17 am
Wyeth LLC and the opinion can be found here. [read post]
22 Feb 2011, 5:02 pm
All of the lawsuits claim that the drug caused patients to develop breast cancer and that the company’s Wyeth unit failed to warn doctors and patients of the potential side effects of hormone replacement therapy. [read post]
20 Feb 2011, 9:21 pm
The lawsuit has named Pharmaceutical Associates Inc., its parent company Beach Products Inc. and Morton Grove Pharmaceuticals Inc. as defendants in the lawsuit. [read post]
15 Feb 2011, 5:26 pm
General Pharma backs calls for extension of TRIPS deadline for least-developed countries (IP Watch) Medicines Patent Pool in talks with Big Pharma (Spicy IP) Protect Pharma sells patent portfolio to Grunenthal GmbH (GenericsWeb) Australia: Federal Court upholds TGA decision to refuse access to documents relating to applications to list generics on the ARTG (IP Whiteboard) EU clarifies statement on ARVs (GenericsWeb) Mexico: Pharma patents in Mexico: an assessment of the current position (IP tango)… [read post]
11 Feb 2011, 7:51 am
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
3 Feb 2011, 2:11 pm
Wyeth, 876 N.E.2d 740, 756 (Ill. [read post]
31 Jan 2011, 8:10 am
Kappos, to Ariad Pharmaceuticals v. [read post]
31 Jan 2011, 8:10 am
Kappos, to Ariad Pharmaceuticals v. [read post]
27 Jan 2011, 5:28 pm
Perrigo Pharmaceuticals Co. [read post]
27 Jan 2011, 5:00 am
KV Pharmaceutical Co., ___ F.3d ___, 2011 WL 148730 (8th Cir. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
24 Jan 2011, 4:58 pm
Perrigo Pharmaceuticals Company (9th Cir. [read post]
20 Jan 2011, 12:50 pm
Sandoz Pharmaceuticals Corp., 487 S.E.2d 70, 74 (Ga. [read post]
13 Jan 2011, 2:55 pm
We put up an initial post about Bausch v. [read post]
10 Jan 2011, 1:55 pm
The opinion cites Wyeth v. [read post]
7 Jan 2011, 11:41 am
The rationale behind passage of the Act was the fear that pharmaceutical companies would stop manufacturing vaccines if they were exposed to litigation for defective vaccines. [read post]
7 Jan 2011, 11:41 am
The rationale behind passage of the Act was the fear that pharmaceutical companies would stop manufacturing vaccines if they were exposed to litigation for defective vaccines. [read post]
